EVD Segment Leads Global Intracranial Pressure Monitor Market

With the increased prevalence of traumatic brain injuries and hemorrhage, intracranial pressure monitors are undergoing quick and innovative technological advancement in order to establish an effective treatment regimen. Factors such as growing geriatric population, increasing traffic-related accidents, worldwide increase in the number of trauma care centers are driving the growth of the global intracranial pressure monitors. However, infections associated with the invasive nature of intracranial pressure monitors market might pull back the growth of intracranial pressure monitors market

Based on type, the global intracranial pressure monitors market has been segmented into external ventricular drain, fiberoptic monitors, strain gauge transducers, and air pouch devices. The external ventricular drain segment accounted for the largest share of the intracranial pressure monitors market in terms of revenue in 2014. External ventricular drain is extremely easy to operate and affordably priced which contributes towards the large market share of the external ventricular drain market. However, air pouch devices is expected to grow at the highest CAGR during the forecast period as these devices furnish accurate measurements coupled with lowest zero-drift characteristics.

The application segment in the intracranial pressure monitors market has been categorized into traumatic brain injury, intracerebral hemorrhage, meningitis, subarachnoid hemorrhage, and others. Traumatic brain injury was witnessed as the largest segment in terms of revenue in 2014. The dominance of traumatic brain injury was attributed to increasing incidences of sport injuries, and traffic-related accidents. The segment is also expected to expand at the highest CAGR due to rising cases of hospitalization every year related to traumatic brain injury.

Based on end-user, the intracranial pressure monitors market has been categorized into trauma centers and hospitals. Trauma centers held the largest market share in 2014 due to increasing rate of traumatic accident cases coupled with 24x7 availability of specially trained healthcare experts in trauma centers. The segment is also expected to grow at the highest CAGR during the forecast period.

Request For Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6445

Geographically, North America accounted for the largest share of the global intracranial pressure monitors market in 2014. Factors attributed to the dominant position of North America in intracranial pressure monitors market are growing geriatric population, high prevalence of brain injuries, with acceptance of technologically advanced intracranial pressure monitors. However, Asia Pacific is anticipated to witness the highest growth during the forecast period. Fastest growth rate in this region is anticipated to emerge due to high prevalence of presence of large base of geriatric population, increasing accident rate leading to head injuries, and improving healthcare infrastructure. In addition, easy market penetration and skilled workforce in developing countries of Asia Pacific would further boost the growth of the intracranial pressure monitors market.

The global intracranial pressure monitors market is fragmented due to the presence of numerous established as well as emerging players. The prominent companies operating in the intracranial pressure monitors market are Codman & Shurtleff, Inc., Haiying Medical, HeadSense Medical, Inc., Integra LifeSciences Corporation, Medtronic, Inc., Raumedic AG, SOPHYSA, and Spiegelberg GmbH & Co. KG.

Heart Blocks Treatment Market – Historical, Current and Projected industry size and Recent Industry Trends by 2020

Heart block is a disease of electrical system of the heart that controls the rate and rhythm of the heart. A heart block occurs if there is slowed and disturbed electrical signals while travelling to heart. People have inherited congenital heart blocks as well as acquired heart blocks that develop after birth. Based on the working of electric signal, heart block is of two type’s namely partial heart block and complete heart block. In partial heart block, the electrical signals are blocked partially i.e., their arrival to the heart is delayed. In complete heart block, signals transmission gets blocked completely.

Read Full Report on Heart Blocks Treatment Market

Heart blocks are also classified as sinoatrial node (SA node) nodal block, atrioventricular node (AV node) nodal block and infra-Hisian blocks. SA node block is not hazardous since, the alternate of SA node i.e., AV will function in place of SA node and would start beating at higher rate to compensate the blood flow. As compared to SA node, AV node block is serious a condition as the functionality of AV node is not taken by other heart components. Block of distal conduction system of heart is known as infra-Hisian block.

Heart blocks can also be segmented as first degree heart block, second degree heart block and third degree heart block. In first-degree heart block, electrical signals are slowed as they move from atria (upper chamber of heart) to ventricles (lower chamber of heart). Usually, first-degree heart block does not cause any symptoms and hence do not require treatment. In second degree heart block, electrical signals are slowed in large degree between atria and ventricles. Sometimes, several signals don\'t reach ventricles. If electrical signals do not reach ventricles, they won\'t contract and pump blood to the lungs along with the rest of body. Second degree heart blocks are of two types: Mobitz type I and Mobitz type II. In third degree heart block, none of the electrical signals reach to ventricles resulting in complete heart block.

Treatment of heart block depends upon the type of heart block a patient is suffering from. In first-degree heart block, usually no treatment is required. In second degree heart block, cardiologist place pacemakers over the skin of abdomen or chest. Pacemaker is also suggested to the patients suffering from third degree heart block. Pacemaker is a device that utilizes electrical signals to initiate heart beat at standard rate.

Request for Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2573

The market for heart block treatment is poised to grow at a significant CAGR during 2014 to 2020. This is due to increasing number of patients suffering from one or other heart block. In addition, age also play a crucial role for developing heart block. Older the people higher the risk for acquiring heart stroke. Hence, aging population will substantially propel the growth of heart block treatment market. The World Health Organization (WHO) estimated that in 2010, around 524 million people were old and has projected that nearly 2 billion people belong to geriatric population by 2050. Similarly, rising incidences of hypothyroidism will further accentuate the growth of heart block treatments market. This is due to the fact that people with hypothyroidism easily acquire heart blocks.

Some of the major players operating in the heart block treatment market include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., BIOTRONIK SE & Co. KG.and SORIN S.p.A. amongst other significant players.

Peritoneal Dialysis Market - Global Industry Analysis, Trends and Forecast 2015 - 2023

The number of people suffering from chronic diseases such as hypertension and diabetes has increased tremendously in recent years. A rise in these chronic ailments ash resulted in increased incidence of kidney failure, thereby driving the global peritoneal dialysis market. In a report, titled “Peritoneal Dialysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023,” Transparency Market Research carefully examines the workings of the worldwide peritoneal dialysis market and the major factors that drive and restrain it.

Peritoneal dialysis has a number of advantages over hemodialysis: no use of needles, minimal visits to the clinic, continuous therapy similar to the natural functioning of the kidney. Peritoneal dialysis is best suited to patients who prefer to do the dialysis at home. On the flip side, the risk of infection and the placement of a permanent catheter are a few of the disadvantages that peritoneal dialysis presents.

The research report studies the global peritoneal dialysis market on the basis of several parameters: service, product, application, and geography. By service, the peritoneal dialysis market is bifurcated into education and homecare services. On the basis of product, the peritoneal dialysis market is segmented into implantation systems, peritoneal dialysis catheters, peritoneal solutions, and other accessories. Based on application, the peritoneal dialysis market is categorized into continuous ambulatory peritoneal dialysis and automated peritoneal dialysis.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4776

The peritoneal dialysis market is geographically segmented into Europe, Asia Pacific, North America, and Rest of the World. North America constitutes the largest share in the overall peritoneal dialysis market due to factors such as the increased adoption rate of advanced technologies, the rising number of dialysis centers, the growing prevalence of hypertension and diabetes, the availability of well-equipped hospitals and dialysis centers and skilled nephrologists, and the presence of a structured reimbursement system in the region. Europe is also a major market for peritoneal dialysis and is driven by the high accessibility of products and services and the increased level of awareness. Asia Pacific is projected to exhibit strong growth in the coming years owing to the rising number of public- and privately-owned dialysis centers, the presence of a massive patient pool, an increase in government initiatives, and gradually improving insurance and reimbursement scenario.

The competitive landscape of the global peritoneal dialysis market is evaluated in the research report by identifying the major players and then reviewing their performance and contribution towards the development of the peritoneal dialysis market. Some of the notable players are Diaverum Deutschland GmbH, Nikkiso Co. Ltd. (Japan), B. Braun Melsungen AG, NxStage Medical, Inc., Nipro Corporation, Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, DaVita Healthcare Partners, Inc., and Asahi Kasei Corporation.

Effect of Laboratory-Developed Testing on Healthcare Industry

A laboratory-developed test (LDT) is a kind of in-vitro diagnostic test that faces a limitation of being developed, manufactured and processed within an individual laboratory. In the United States, the federal government regulates the development, manufacturing and use of LDTs through the Centers for Medicare and Medicaid Services (CMS) and the Clinical Laboratory Improvement Amendments (CLIA). In July 2014, the United States Food and Drug Administration (FDA) announced to start regulating some LDTs. A number of LDTs are commercially available for the analysis of substances such as DNA, proteins, glucose and cholesterol in sample taken from human beings. There are many hospitals and laboratories that prefer to offer their own LDTs, even though FDA-approved in-vitro diagnostic tests are available on the market for the same analyte. LDT developers cannot sell their proprietary tests to hospitals, clinical laboratories and physician offices directly, and hence, adopt a business model wherein they enter into partnerships with diagnostic service providers and pathology labs that collect the sample and ship it to them.

Globally, the market for laboratory-developed testing is expanding year on year at double digit rate. Continued developments in technology leading to the introduction of new LDTs, growing demand for personalized treatment and consistent rise in overall patient population are among the major factors driving the market for laboratory-developed testing. In October 2011, Sequenom, Inc. introduced a laboratory developed non-invasive prenatal test, MaterniT21 (now MaterniT21 PLUS) for the determination of fetal chromosomal aneuploidies by analyzing the fetal cell-free DNA circulating in the maternal blood. NIPTs are contributing significantly in the overall growth of laboratory-developed testing market. FDA approved in-vitro diagnostic tests that are considered safe and accurate than LDTs, are expected to affect the laboratory-developed testing market growth to some extent.

Request For Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5252

In terms of geography, the global market for laboratory-developed testing can be categorized into four major regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). North America represented the largest regional market for laboratory-developed testing in 2013. Reimbursement coverage for major LDTs has been one of the major reasons responsible for North America holding leading position in terms of laboratory-developed testing market across the globe. Europe was the second largest market for laboratory-developed testing after North America in 2013. In Asia-Pacific region, the laboratory-developed testing market is expected to grow under the influence of factors such as the presence of a large pool of patients suffering from various diseases and emerging economy of countries including India, and China. In RoW region, Latin America, Middle East and Africa are the most potential markets. Continuously improving healthcare infrastructure of these regions is expected to play a key role in driving the growth of laboratory-developed testing market.

Sequenom, Inc., Quest Diagnostics, Laboratory Corporation of America Holdings (LabCorp), ARUP Laboratories, Myriad Genetic Laboratories Inc., Precision Therapeutics Inc., RedPath Integrated Pathology, Inc. and CardioDx are some major diagnostic laboratories that are engaged in the business of laboratory-developed testing. Sequenom Laboratories, a business subsidiary of Sequenom, Inc. offers a variety of LDTs related to non-invasive prenatal and women’s health and other diseases such as cancer, autoimmune and neurological disorders. MaterniT21 PLUS, HerediT CF, SensiGene RHD and RetnaGene AMD are the LDTs being developed and marketed by Sequenom Laboratories. Some other examples of LDTs include Corus CAD by CardioDx, ChemoFx assay by Precision Therapeutics Inc. and PathfinderTG by RedPath Integrated Pathology, Inc.

DNA Chip Market : Challenges and Opportunities

A DNA chip, also referred to as a DNA microarray, is comparable to a computer chip. The key differentiating factor between the two is that a computer chip is imbedded with electronic circuitry, whereas a DNA gene chip is imbedded with DNA molecules. Or else it can be stated that DNA chip is a collection of DNA spots that are embedded on the solid surface. A DNA gene chip is about the size of a postage stamp. This technology has become very popular in the drug discovery and medical research sector as it significantly brings down research time. DNA microarrays play a vital role in helping medical researchers simultaneously measure the expression levels of several thousands of genes. The spiraling popularity of DNA chips has prompted many new players to enter the market and profit from their growing demand. In view of these aspects, the market for DNA gene chips is projected to show double-digit growth over the forecast period of this report. This technology is used to measure the expression levels of thousands of gene together at the same time.

Based on type, DNA gene chip market can be split into oDNA (oligonucleotide DNA) and cDNA (complementary DNA). The former is a dominant segment in the market, accounting for over 95% of the overall market share. The DNA gene chip market can also be classified by application as: comparative genomic hybridization, gene expression profiling, geneID, and others. The gene expression market emerges as the largest owing to its extensive applications in agriculture, clinical diagnostics, and other emerging sectors. This segment will likely demonstrate healthy growth over the forecast period as a result of substantial funding from governments and private players alike.

Request For Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4310

The report studies the DNA gene chip market based on geography by classifying it as: North America, Europe, Asia Pacific, and others. While North America was the dominant market in this sector until a few years ago, it is projected to reach maturity very soon and slip from its top position. On the other hand, aggressive growth in Asian economies such as China, Singapore, India, and South Korea will lead to a shift in the dynamics of the DNA microarray market. These markets are poised for massive growth as drug discovery and clinical trials intensify here.

Vital aspects of value of the DNA gene chip market include a strong supply chain, world-class logistical connectivity, cutting-edge scientific infrastructure, and the availability of skilled manpower. Singapore boasts leadership on all these fronts, making it a hub for the DNA gene chip market. Most of the companies are focing on setting up of facilities in this region due to strong intellectual property laws, logistics connectivity and supply chain.

Growth in personalized medicines, rising prevalence of cancer, technology advancements and large scale initiatives by the organization are some of the major drivers of this market. According to the World Health Organization (WHO) worldwide 8.2 million people died of cancer in 2012. In 2013, American Cancer Society (ACS) published that, around 300,000 men and 276,000 women died due to cancer in 2012 in the U.S. Moreover, California Journal of Clinical Cancer (CJCC) stated that, one in the every six U.S. men have received diagnosis test for prostate cancer at some point in their lives. Hence, such high prevalence of diseased condition would raise the growth of the market to a higher end.

Some of the majors players of the DNA chip market include Affymetrix, Inc., Agilent Technologies, Biomérieux Sa, Biometrix Technology Inc, Capitalbio Corporation, Bioneer Corporation, Eurofins Mwg Operon, Illumina Inc., Greiner Bio-One, Lc Sciences, Life Technologies Corporation, Microarrays Inc, Macrogen Inc, Sequenom Inc, Scienion Ag, Sigma-Aldrich, Savyon Diagnostics Ltd, Roche Nimblegen Inc, Wafergen Biosystems Inc and others.

Digital and Portable Imaging Equipment to Lead Global Medical Imaging Equipment Market

According to a recent market research report published by Transparency Market Research, the global medical imaging equipment market is projected to expand at a CAGR of 5.6% during the period between 2015 and 2023. The report, titled “Medical Imaging Equipment Market - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2015 - 2023”, estimates the global medical imaging equipment market to reach a valuation of US$45.3 bn by 2023. The overall market was worth US$27.7 bn in 2014.

The report points out that the growing prevalence of target diseases and rapidly increasing geriatric population will fuel the demand for medical imaging equipment. Rise in demand for 3D medical imaging equipment, coupled with initiative taken by government and private organizations, will further propel the growth of the global medical imaging equipment market. However, the increasing pressure on healthcare budgets in the U.S. and excise duty imposed on medical device manufacturers will play spoilsport in the growth of the market during the forecast horizon. Low adoption of digital technology-based systems, conventional CT, and MRI scanners among patients will also negatively impact the market. The global medical imaging equipment market has a huge opportunity to grow with the introduction of cloud-based medical imaging.

In terms of product types, the report segments the global medical imaging equipment market into ultrasound systems, X-ray devices, computer tomography (CT) scanners, magnetic resonance imaging (MRI) equipment, and nuclear imaging equipment. X-ray imaging devices dominated the overall market in 2014. The growing prevalence of cardiovascular, respiratory, and gastrointestinal disorders and easy availability of X-ray devices have driven the demand for X-ray imaging devices. Stationary X-ray devices are more in demand compared to portable X-ray equipment devices due to their low cost.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=105

The demand for ultrasound systems is expected to surge during the forecast horizon owing to high adoption rates across the globe. Cost-effectiveness, safety, and real-time image formation are some of the benefits of ultrasound imaging over CT and MRI scans. Earlier, the applications of ultrasound systems were restricted to abdominal imaging. However, they are now extensively used to image the kidneys, heart, and other organs. In ultrasound imaging, the commonly used technologies are 2-D, 3-D, and 4-D imaging, lithotripsy, Doppler, and high intensity focused ultrasound (HIFU). Nuclear imaging devices have emerged as a recent development in the global medical imaging equipment market and are expected to witness wide adoption by the end of the forecast horizon.

Describing competitive landscape, the report profiles some of the key players in the global medical imaging equipment market such as GE Healthcare, Hitachi Medical Corporation, Philips Healthcare, Siemens Healthcare, Shimadzu Corporation, Hologic Inc, Samsung Medison Co. Ltd., Carestream Health Inc., Genesis Medical Imaging Inc., Fonar Corporation, Toshiba Corporation, and Fujifilm Holdings Corporation. The global medical imaging equipment market has witnessed the dominance of a few leading players such as GE Healthcare, Philips Healthcare, Toshiba Corporation, and Siemens Healthcare.

The global medical imaging equipment market is segmented into the following categories:

Medical Imaging Equipment Market, by Product

• X-Ray Devices
  • Stationary
  • Portable
• Ultrasound Systems
  • Cart/Trolley Based Ultrasound System
  • Compact/Portable Ultrasound System
• Computed Tomography (CT) Scanners
  • Stationary
  • Mobile
• Magnetic Resonance Imaging (MRI) Equipment
  • Closed
  • Open
• Nuclear Imaging Equipment
  • SPECT Scanner
  • PET Scanner

Medical Imaging Equipment Market, by Technology

• X-Ray Devices
  • Analog X-ray Technology
  • Digital Radiography
  • Computed Radiography
• Ultrasound Systems
  • 2-D
  • 3-D & 4-D
  • Doppler
  • High Intensity Frequency Ultrasound (HIFU)
  • Lithotripsy
• Computed Tomography (CT) Scanners
  • Stationary
  • Mobile
• Magnetic Resonance Imaging (MRI) Equipment
  • Low-Slice
  • Medium-Slice
  • High-Slice
• Nuclear Imaging Equipment
  • SPECT Scanner
  • PET Scanner

Medical Imaging Equipment Market, by Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)

Contact us:

Mr. Sudip S

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Diagnostic Imaging Market - Worldwide Market Shares, Strategies, and Forecasts 2012 to 2018

Diagnostic imaging techniques, with their ability to effectively monitor diseases while being non-invasive in nature, are being used by an increasing number of diagnosticians. The future of the global diagnostic imaging market, thus, will be shaped by the increasing incidence of new conditions and the prevalence of chronic diseases, which need timely diagnosis. In its report, titled, ‘Diagnostic Imaging Market - Global Industry Size, Share, Trends, Analysis and Forecasts 2012–2018,’ Transparency Market Research conducts a thorough evaluation of the market to present growth projections and a qualitative analysis.

Diagnostic imaging technologies such as X-rays, MRI, and CT scans have seen greater adoption over the past two decades. The previously mentioned advantages of diagnostic imaging technologies can be credited for their increased acceptance in the healthcare industry. The trend of preventative healthcare is gaining traction owing to two key reasons: Patients are now more aware about keeping tabs on their own wellbeing and insurance reforms in several countries have given consumers the power to afford preventative healthcare packages. These trends have augured well for the growth of the global diagnostic imaging market.

Get Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=208

The graying population, especially in countries that experienced a baby boom in between the 1940s and 1960s, is now contributing substantially to the growth of the diagnostic imaging market. This is expected to be yet another factor fuelling the market through the report’s forecast period, which ranges from 2012 to 2018.

According to the report, X-ray is the most widely used diagnostic imaging technology. The use of ultrasound technology for diagnosing diseases and conditions is prevalent as well, but slightly less so than X-ray technology. However, some sections of consumers harbor concerns about the efficacy and safety of diagnostic imaging technologies. For instance, the risk of being exposed to radiation is a concern associated with X-ray-based diagnostic imaging. Thus, companies will have to pay more attention to addressing consumers’ concerns and making diagnostic imaging more pocket-friendly. Convenience will be another factor influencing purchase decisions in the future – healthcare practitioners are now more inclined to use portable and compact diagnostic imaging systems

Some of the restraints faced by the diagnostic imaging market, as discussed in the report include: Saturation in developed economies and underdeveloped health insurance coverage in emerging countries.

The report studies the diagnostic imaging market in the following regions: North America, Asia Pacific, Europe, and Rest of the World. The report also profiles important players in the diagnostic imaging market, with the leaders being: Siemens, Phillips, and GE.

Tissue Engineered Skin Substitutes Market - Global Industry Analysis, Trends, and Forecast 2015 - 2023

Transparency Market Research has published a new report, titled “Tissue Engineered Skin Substitutes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023”. Based on the survey conducted, the report pegs the value of the global tissue engineered skin substitutes market at US$0.9 bn in 2014. The market, exhibiting an impressive CAGR of 17.20% between 2015 and 2023, is likely to reach US$3.8 bn by 2023.

Browse the full Tissue Engineered Skin Substitutes Market (by Type - Acellular, Cellular Allogeneic, Cellular Autologous, and Others; by Application - Burn Injury, Diabetic/Vascular Ulcer, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/tissue-engineered-skin-substitute.html

Artificial skin substitutes or skin substitutes are derived from human tissue, synthetic materials, non-human tissue, or a combination of these materials. Tissue engineered skin substitutes are made up of cells, combination of matrices and cells, and extracellular matrix. In the past few years, the market for tissue engineered skin substitutes has been witnessing growth at a significant pace owing to the rise in the number of vascular ulcer and diabetes patients. Furthermore, as the geriatric population around the world increases, it is subsequently expected to boost the demand for tissue engineered skin substitutes.

The market, according to the report, has gained much demand due to the rise in medical tourism in the emerging economies of Asia. However, despite witnessing lucrative prospects worldwide, the risk of disease transmission and absence of favorable reimbursement policies in major economies could hamper the overall growth of the market during the period from 2015 to 2023, as per the information published in the report.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3854

To provide a holistic overview, the report segments the global tissue engineered skin substitutes market into acellular, cellular autologous, cellular allogeneic, and others. Of these, the acellular skin segment held the largest share of the market in 2014 and is expected to rise at the highest CAGR between 2015 and 2023. The growth of this segment is mainly helped by the low cost and easy availability of these tissue engineered skin variants. Moreover, increasing preference for acellular skin substitutes than implant-based skin surgery is also likely to fuel demand from the global tissue engineered skin substitutes market, states the report. As per the American Society of Plastic Surgeons, more than 50% of plastic surgeons in the U.S. preferred using acellular matrix for skin surgeries in 2012. The growing demand from acellular skin substitutes, particularly from the developed nations, will therefore boost the global tissue engineered skin substitutes market.

In terms of application, the report segments the global market for tissue engineered skin substitutes into diabetic/vascular, burn injury, and others. Of these, the diabetic/vascular segment held the largest share in the market in 2014, and as per the report, the segment will rise at the highest CAGR during the forecast period.To present a comprehensive overview of the market, the report also profiles companies such as BSN medical, 3M Health Care, Mölnlycke Health, Medtronic, Integra LifeSciences Corporation, and Acelity, L.P., Inc.

Read Full Press Release: http://www.transparencymarketresearch.com/pressrelease/global-tissue-engineered-skin-substitute.htm

The global tissue engineered skin substitutes market is segmented as follows:

Global Tissue Engineered Skin Substitutes Market, by Type

• Acellular
• Cellular Allogeneic
• Cellular Autologous
• Others

Global Tissue Engineered Skin Substitutes Market, by Application

• Burn Injury
• Diabetic/Vascular Ulcer
• Others

Global Tissue Engineered Skin Substitutes Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • U.K
  • Germany
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • Rest of APAC
• Latin America (LATAM)
  • Brazil
  • Mexico
  • Rest of LATAM
• Middle East & Africa (MEA)
  • South Africa
  • Rest of MEA

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Mr. Sudip S

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Traumatic Brain Injury Segment to Lead Global Intracranial Pressure Monitors Market

The latest report, titled “Intracranial Pressure Monitors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”, from Transparency Market Research (TMR) delivers a 360-degree view of the market.According to this report, the global intracranial pressure monitors market will progress at a 6.40% CAGR during the forecast period from 2015 to 2023. In 2014, the global intracranial pressure monitors market was estimated at US$210.5 mn and by 2023, the market will be worth US$350.5 mn.

Browse the full Intracranial Pressure Monitors Market (Type: External Ventricular Drain, Fiberoptic Monitors, Strain Gauge Transducers, and Air Pouch Devices; Application: Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, Subarachnoid Hemorrhage, and Others; End-user: Trauma Centers and Hospitals) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023 report at http://www.transparencymarketresearch.com/intracranial-pressure-monitors-market.html

Intracranial pressure monitors are medical devices supporting the measurement of the pressure inside the skull during critical care. The global intracranial pressure monitors market is driven by the sustained rise in the incidence of traumatic injuries. Furthermore, the elevated health care expenditure worldwide, along with the rising occurrence of stroke incidents globally, will drive the global intracranial pressure monitors market. On the other hand, infections arising from the invasive nature of intracranial pressure monitors will challenge the global intracranial pressure monitors market’s growth.

By type, the global intracranial pressure monitors market is segmented into air pouch devices, strain gauge transducers, fiberoptic monitors, and external ventricular drain (EVD). The EVD segment held the largest share (more than 35%) in the global intracranial pressure monitors market in 2014. EVDs are easy to use and extremely affordable, driving their demand in the market. Furthermore, EVD can be re-zeroed during any point of time, further driving their popularity among consumers. On the other hand, the air pouch devices segment will enjoy the highest CAGR during the forecast period due to the low zero-drift features offered by air pouch devices.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6445

Application-wise, the global intracranial pressure monitors market is divided into subarachnoid hemorrhage, meningitis, intracerebral hemorrhage, traumatic brain injury, and others. The traumatic brain injury segment held the largest share in the global intracranial pressure monitors market in 2014. Factors such as the rising incidence of traffic-related accidents, violence, and sports injuries are fuelling this segment. On the basis of end use, the global intracranial pressure monitors market is segmented into hospitals and trauma centers. The trauma centers segment led the global intracranial pressure monitors market in 2014 due to the round-the-clock availability of trained healthcare providers and growing number of critically ill patients.

Region-wise, the global intracranial pressure monitors market is classified into Asia Pacific, Europe, North America, and Rest of the World (RoW). North America held more than 50% of the global intracranial pressure monitors market. The North America intracranial pressure monitors market benefits from the elevated awareness of consumers, improved healthcare infrastructure, and high acceptance of advanced monitoring equipment.

Read Full Press Release: http://www.transparencymarketresearch.com/pressrelease/global-intracranial-pressure-monitors-market.htm

Players in the global intracranial pressure monitors market will benefit from the shift from invasive to non-invasive monitoring devices. Emerging economies also offer good sustained growth opportunities to companies. Some of the key players operating in the global intracranial pressure monitors market are Spiegelberg, Raumedic, Medtronic, Integra LifeSciences, HeadSense Medical, Haying Medical, and Codman & Shurtleff.

Key Segments of the Global Intracranial Pressure Monitors Market

Intracranial Pressure Monitors Market, by Type

• External Ventricular Drain
• Fiberoptic Monitors
• Strain Gauge Transducers
• Air Pouch Devices

Intracranial Pressure Monitors Market, by Application

• Traumatic Brain Injury
• Intracerebral Hemorrhage
• Meningitis
• Subarachnoid Hemorrhage
• Others

Intracranial Pressure Monitors Market, by End-user

• Trauma Centers
• Hospitals

Intracranial Pressure Monitors Market, by Geography

• North America
• Europe
• Asia Pacific (APAC)
• Rest of the World (RoW)

About Us:

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact:

Mr.Sudip S

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Medical Cameras and Microscopes Market to Rise at 4.0% CAGR till 2023, Propelled by Demand for Surgical Microscopes

Transparency Market Research (TMR) announces the release of a new study, titled “Medical Cameras and Microscopes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023”, to its repository. The 83-page report is compiled to present insights into the prevailing dynamics and future prospects of the global medical cameras and microscopes market. Based on in-depth primary and secondary research, the study forecasts the global medical cameras and microscopes market to exhibit a moderate yet positive CAGR of 4.0% between 2015 and 2023. The market in 2014 stood at US$0.9 bn and it is expected to reach US$1.3 bn by the end of 2023.

Browse the full Medical Cameras and Microscopes Market (Medical Cameras by Specialty (Endoscopes, Dermatology, Dental, Ophthalmology, Surgical Microscope, and Pathology Microscope); Microscopes by Type (Surgical and Pathology) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2015 – 2023 report at http://www.transparencymarketresearch.com/medical-cameras-market.html

According to the World Health Organization’s (WHO) factsheet released in 2011, the global population will increase by nearly 33% in the next decade. Furthermore, the WHO projects the geriatric population to more than double in the next few years and also predicts that over 32 mn cataract surgeries will be performed across the globe by 2020.

The growing geriatric population worldwide and rising incidence of chronic illnesses requiring surgical intervention augments the demand for medical cameras and microscopes. For the purpose of the study, the report segments the global cameras and microscopes market into the various types of medical cameras and microscopes available in the market. The segment of microscopes comprises surgical and pathology microscopes. The surgical microscopes segment is further sub-segmented in terms of application into ENT, ophthalmology, neurosurgery, and others.

Get free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1619

The pathology microscopes segment, in terms of end use, is broken down into diagnostic laboratories, hospital laboratories, and physician’s offices. Likewise, the medical cameras segment is classified on the basis of type into dental, ophthalmology, endoscopy, dermatology, pathology, and surgical microscope cameras. According to the report, the segment of microscopes held about 51% of the global medical cameras and microscopes market in 2014. Among the sub-segments of microscopes, surgical microscopes held over 90% of the market in 2014.

Based on geography, the global market for medical cameras and microscopes is segmented into Asia Pacific, Europe, Latin America, North America, and Rest of the World (RoW). Among these, North America held the largest share in the global market for medical cameras and microscope, followed by Europe in 2014. Speaking about the most lucrative markets for medical cameras and microscopes, a lead TMR analyst said, “North America has remained an early adopter of the latest advances introduced in the healthcare sector, which made the region the leading market for medical cameras and microscopes. Additionally, the rising geriatric population in the region will also fuel the market significantly”.

Read Full Press Release: http://www.transparencymarketresearch.com/pressrelease/global-medical-cameras-market.htm

According to the report, Asia Pacific held the third largest market share in 2014. However, the region is expected to exhibit the fastest CAGR during the aforementioned forecast period. The increasing healthcare investment, growing awareness among common people, and rising geriatric population will augment demand from the Asia Pacific market for medical cameras and microscopes, states the report.

Global Medical Cameras Market, by Type

• Endoscopy Cameras
• Dermatology Cameras
• Ophthalmology Cameras
• Dental Cameras
• Surgical Microscope Cameras
  • Ophthalmology
  • ENT
  • Neurosurgery
  • Others
• Pathology Microscope Cameras
  • Hospital Laboratories
  • Diagnostic Laboratories
  • Physician Offices

Global Microscopes Market, by Type

• Surgical Microscopes
  • Ophthalmology
  • ENT
  • Neurosurgery
  • Others
• Pathology Microscopes
  • Hospital Laboratories
  • Diagnostic Laboratories
  • Physician Offices

Global Medical Cameras and Microscopes Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • Rest of Europe
• Asia Pacific (APAC)
  • Japan
  • China
  • Rest of APAC
• Latin America (LATAM)
  • Brazil
  • Mexico
  • Rest of LATAM
• Rest of the World (RoW)
  • Middle East & North Africa
  • South Africa
  • Russia
  • Rest of RoW

About Us:

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact:

Mr.Sudip S

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Global Report on Electronic Medical Records Market

A growing number of healthcare institutions around the world are adopting electronic medical record (EMR) systems. Electronic medical records form an integral part of the advancing healthcare IT industry. The technological benefits of EMRs are projected to drive the overall efficiency of healthcare institutions. In addition to this, the higher efficiency of paperless administration is also supporting the growth of the global electronic medical records market.

Increasing Portability and Accessibility of EMRs to Drive Global Market

A paperless administration in a healthcare setting is a more sustainable and scalable set up. Furthermore, this setup helps minimize errors in a healthcare facility and also helps store data in a centralized repository, which will further fuel the global electronic medical records (EMRs) market.

Besides the rising demand for paperless administration, the global electronic medical records (EMRs) market will also benefit from the rising portability and accessibility of medical document management systems. Moreover, the global electronic medical records market will also be driven by the rising technological developments and modernization in the healthcare management system.

It is now widely accepted that the broad adoption of electronic medical record (EMR) systems will result in major healthcare savings, improved efficiency, and improved health outcomes for patients. On the basis of end users, the global electronic medical records market is segmented into home health agencies, clinics and nursing homes, and hospitals.

Read Full Article: http://www.transparencymarketresearch.com/article/electronic-medical-records-market.htm

North America to Lead Global EMRs Market

By geography, the global electronic medical records (EMRs) market is divided into North America, Asia Pacific, Europe, and Rest of the World (RoW). The Western markets of North America and Europe are projected to witness good growth in the coming years. North America is leading the global electronic medical records market, trailed by Europe.

The North America electronic medical records (EMRs) market is driven by the favourable healthcare reforms and federal incentives to contain healthcare-related costs. In addition to this, this regional electronic medical records market also benefits from the growing demand for integration of healthcare systems, improved patient care due to EMR implementation, rising share of IT in healthcare expenditure, and the elevated return of investment (ROI) via efficient utilization of EMRs.

Asia Pacific is expected to emerge in the global electronic medical records (EMRs) market as the most promising regional market. Some of the factors supporting the growth of this regional EMR systems market are the rising demand for better quality of care and growing initiatives from governments to opt for patient flow management solutions and electronic health records (EHRs). Further, the accelerating need to improve management of patient data and reduce record retention costs will also drive this regional electronic medical records market.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6526

Companies in Global EMR Systems Market Offering Novel Solutions

The global electronic medical records (EMRs) market is highly competitive in nature and is marked with the presence of several international and domestic key players. The firms operating in the global electronic medical records market are offering novel systems and software to drive demand for digital management of health information. These companies have helped simplify the complex medical records and successfully achieved quality incomes. Two of the key software delivery modes in the global electronic medical records market are cloud and on-premise.

Some of the top companies operating in the global electronic medical records (EMRs) market are 3M Company, Hyland Software, Toshiba Medical Systems Corp., McKesson Corporation, Allscripts Healthcare Solutions, Epic Systems, and GE Healthcare. In 2010, Allscripts stood out as the market leader in the U.S. electronic medical records market.

Browse Full Global Electronic Medical Records (EMRs) Market Report With Complete TOC @ http://www.transparencymarketresearch.com/electronic-medical-records-market.html

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Mr. Sudip S

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Protein Analyzers Market Segment Forecast up to 2023

Proteins are large biomolecules found throughout the body, from bones to muscles, skin, and hair. They consist of a large chain of amino acids and perform an array of functions such as DNA replication, catalyzing metabolic reactions, and transportation of molecules from one place to another within the human body. Protein analyzers are used by the food and beverages industry to determine the content of N-protein in food and beverages. Due to their surging demand, protein analyzers are now commercially available in the market. Some of the popular examples of protein analyzers include FLASH 4000 N and FLASH 2000 N/Protein analyzer by Thermo Fisher Scientific, Inc., VELP Scientifica’s Dumas Nitrogen Analyzer, Euro Vector’s N-Protein Analyser, and FP528 Nitrogen/Protein by LECO Corporation that are available in the category of organic samples.

In its latest report, Transparency Market Research – a leading research intelligent firm – projects robust growth for the global protein analyzers market in the near future.

Read Full Article: http://www.transparencymarketresearch.com/article/protein-analyzers-market.htm

Majority Demand for Protein Analyzers Arises from Food and Beverages Industry

Increasing investment and extensive research and development initiatives in the field of protein analyzer manufacturing have led to the development of several technologically advanced products. These efforts have also resulted in rapid expansion of the food and beverages industry. For instance, the leading names in the food and beverages industry use Flash 4000 N/Protein analyzer to analyze the presence of N-protein in the manufacturing of a plethora of human food such as cheese, meat, cereals, milk, fertilizers, beverages, and beer, as well as animal feed. This analyzer enables analyzing the protein content in multiple samples in less than 7 minutes. The demand for protein analyzers arises from the most popular food and beverages brands, since consumers nowadays are more informed and they demand healthy food products. The rapid expansion of the food and beverages industry therefore significantly fuels the demand from the global protein analyzers market.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4315

North America and Europe Lead Global Protein Analyzers Market

The four key regional markets for the global protein analyzers industry are Asia Pacific, North America, Europe, and Rest of the World. Among these regions, Europe and North America represented the largest share of the market in 2013. The lead of these regions is due to the presence of a large number of protein analyzer manufacturers in the U.S. and various European countries. In terms of revenue, the Asia Pacific market for protein analyzers holds the third largest share. The market also exhibits high growth potential, particularly in countries such as India, Australia, Japan, China, South Korea, Singapore, and New Zealand.

Vendor Landscape of the Global Protein Analyzers Market

Some of the leading players operating in the global protein analyzers market are LECO Corporation, Thermo Fisher Scientific, Inc., CE Elantech, Inc., Life Technologies, VELP Scientifica, and Euro Vector. These players are engaged in fierce competition with each other to gain a competitive edge in the market. Furthermore, these players often have to face tough competition from local manufacturers in countries such as India, Brazil, China, and South Africa.

Browse Full Global Protein Analyzers Market Report With Complete TOC @ http://www.transparencymarketresearch.com/protein-analyzers-market.html

Global Tissue Engineered Skin Substitutes Market expected to reach USD 3.8 Billion in 2023

Tissue engineering is a sophisticated yet promising treatment option for the treatment of skin diseases and disorders. Tissue engineering entails the development of biological substitutes to restore damaged tissue or maintain tissue function via the use of both cellular and acellular materials. It thus calls for close collaboration between cell biologists, geneticists, clinicians, and other experts. With skin disorders and diseases on the rise, coupled with the booming medical tourism industry, the prospects of the tissue engineered skin substitutes market look promising.

The global tissue engineered skin substitutes market is on the brink of explosive growth over the next few years as more advances in the field are made. The fact that the tissue engineered skin substitutes market will grow at 17.2% CAGR between 2015 and 2023 also speaks volumes about the high degree of innovation that prevails in the market. According to Transparency Market Research, tissue engineered skin substitutes constituted a US$958.8 mn market. The market is expected to surge to US$3.8 bn by 2023. Acellular tissue engineered skin substitutes are more popular than cellular substitutes because of the comparatively attractive price that the former boast.

Browse Full Article: http://www.transparencymarketresearch.com/article/tissue-engineered-skin-substitute.htm

Use of Tissue Engineered Skin Substitutes was Highest for Diabetic Ulcers in 2014

The WHO predicting that diabetes will be the 7th leading cause of death by 2030 is indicative of the pandemic proportions this disease has attained. An alarming 25.0% of diabetics are diagnosed with diabetes-related ulcers, said the International Diabetes Federation in 2014. These ulcers can take months on end to heal even when great precautions are taken. In the case of acute 

For patients suffering from acute diabetic ulcers, skin substitutes are, in most cases, the only available option if they are to prevent their quality of life from being compromised. As a result of this, the demand for tissue engineered skin substitutes will continue to remain high from patients suffering from diabetic ulcers. 

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3854

Tissue Engineered Skin Substitutes Market Currently Concentrated in North America

The availability of a wide variety of tissue engineered skin substitutes is in itself the key factor responsible for keeping North America at the top of the global market. This wide choice of products on its part can be ascribed to the high prevalence of diabetes in North America. Besides diabetes, deep vein thrombosis (DVT) continues to impose an increasing burden on healthcare agencies in the U.S. The Centers for Disease Control and Prevention (CDC), in its report published in March 2015, says that about 900,000 people in the United States are diagnosed with DVT per year. Ulcers and lesions resulting from DVT are contributing to the demand for tissue engineered skin substitutes in North America. 

However, when it comes to lifestyle-related diseases, the Asia Pacific is inching closer to North America owing largely to the increasing affluence in countries in the former. Moreover, a sizeable aging population base in countries such as Japan, Singapore, and China put persons in this age group at a higher risk of diabetes and DVT. Thus, the investment potential of Asia Pacific will only continue to rise over the next few years. 

Browse Full Global Tissue Engineered Skin Substitutes Market Report With Complete TOC @ http://www.transparencymarketresearch.com/tissue-engineered-skin-substitute.html

Contact us:

Mr. Nachiket
Transparency Market Research
90 State Street, 
Suite 700, 
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/